Injection of new psychoactive drugs in Romania multi-indicator analysis

Similar documents
The evolution of the HIV/AIDS outbreak among IDUs in Romania

Consumption of new substances with psychoactive effects (NSPE)

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

Annual report 2009: the state of the drugs problem in Europe

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic

New patterns of drug use in Hungary

Workshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Trends in injecting drug use in Europe

Annual report 2012: the state of the drugs problem in Europe

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Drug consumption among roma population

Overview of drug-induced deaths in Europe - What does the data tell us?

Most recent data, analyses and feed-back from the 2016 DRID national updates

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)

Trends in cannabis use and cannabis-related treatment demand in Switzerland

2011 NATIONAL REPORT (2010 data) TO THE EMCDDA by the Reitox National Focal Point ROMANIA

The issues facing Europe

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

Poland nationalupdate

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

NPS use, harms and health responses to NPS in Europe: findings form multi-method studies

The Polish legislation on smart shops

New trends in harm reduction in Europe: progress made challenges ahead

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

INTRAVENOUS INJECTING DRUG USE.

First results collected by Argos, DCR in Strasbourg opened in november 2016

Changes in the NPS market in Eastern and Central Europe

Perspectives for information on alcohol use in the EU

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Public drug policies Catalonia

Global drug trends and sustainable development

World Drug Report 2017

Focal Point Ireland: national report for 2016 Drugs Ireland

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Bulgaria Bulgaria Drug Report 2018

FACT SHEET SERBIA (REPUBLIC OF)

Session I. Update on synthetic cathinones injection in Hungary

JSNA Substance Misuse

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Recent trends in drug problems and service provision in Greece

FACT SHEET TAJIKISTAN (REPUBLIC OF)

TDI 3.0 implementation. TDI Prevalence. Linda Montanari, Bruno Guarita

Strategies of drug users to avoid infection with hepatitis C

EMCDDA trend report for the evaluation of the EU drugs strategy

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

The Netherlands Drug Situation Summary

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

FACT SHEET 1 IRAN (ISLAMIC REPUBLIC OF)

Combination of various data bases and estimation methods to better estimate the market from the demand and the supply side and consequences

WORLD DRUG REPORT 2011

Illicit drug use in prisons

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe

Harms and harm reduction workbook. Country X

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Focal Point Ireland: national report for harms and harm reduction

Cannabis trends in France TDI data

ORGANIZATION OF AMERICAN STATES

Drug situation in Greece

Click for Support REALized

Expert Peer Review for Carfentanil

Cyprus Focal Point Report 2014

Models of good practice in drug treatment in Europe. Project group

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

The epidemiology of HIV infection in Greece HIV/AIDS reporting system

NPS Current situation in Czech Republic. RICHTER Jiri, SANANIM

Legal and institutional framework of combating drugs abuse in the. Republic of Croatia

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,

Present and potential perspectives for information on alcohol use in the EU

Nigerian Epidemiological Network on Drug Use (NENDU)

Controlled Substances

Drug Consumption Rooms Worldwide

The drugs situation in Ireland: an overview of trends from 2005 to 2015.

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

Clients profile by groups in France Why to use group classification?

ANNUAL REPORT ON THE DRUG PHENOMENA. Commissioned by the European Monitoring Centre on Drugs and Drug Addiction IPDT 1

Hepatitis prevention in the context of HIV prevention point work in Latvia

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Horizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Addictions and Lifestyles in Contemporary Europe. Reframing Addictions Project

In order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.

8.0 Take Home Naloxone

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Informal meeting of the Justice and Home Affairs Ministers Sopot July 2011

59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016

Hungary Hungary Drug Report 2018

Syntetic opioids and NPS. Håkan Leifman Director

Methamphetamine use in the Czech Republic

Transcription:

Injection of new psychoactive drugs in Romania multi-indicator analysis Psycho-Sociologist Lavinus Sava - RNAA LISBON 26-27 October 2013

Romania, 2012 2012 stabilization of drug phenomenon in Romania, both in terms of demand and supply (after 3 years of changes: reorganizing the NAA and the NPS outburst) The (epidemic) outbreak of HIV infection among the IDUs notified since two years ago continues. (31% of all new reported HIV infected cases comes from the IDUs National Comision for fighting against AIDS, within Health Ministry) The NPS still the main problem in sight for the antidrug public policy system.

DATA SOURCES Recent studies/projects PDU estimates Key and core indicators (TDI, DRID, DRD, non-fatal drug emergencies) Supply indicators ROUTINE MONITORING of the implementing of the National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health

PDU estimates 2011 - an estimated number of 19,265 (95% CI: 14,564 26,296) problem drug users in Bucharest (1967 clients of treatment services for intensive use of opioids, NPS, cocaine and amphetamines) 2012-1110 cases of IDUs in treatment (heroin- 823/ 74,2% cases and NPS- 247/25,8% cases reporting almost all the use of metamphetamihe-like substance called PURE) 4

NAA/ARAS/CARUSEL PROJECT The NAA set up a harm-reduction pilot project in 2012, distributing 142 500 syringes to the IDUs from Bucharest, using the facilities of two partner NGOs : ARAS and CARUSEL. The analysis of the data collected through this program (may- december 20120) indicates: 1326 IDUs registered (60% by ARAS, 40% by Carusel) 3934 contacts to the NSP units (87,4% to the 3 drop-in centers and 12,6% to the mobile outreach teams) an average of 3 contacts/client. 78% of the clients are male clients. the most prevalent age group was the 25-34 years one. all of the clients registered are IDUs, 3,4% declare themselves sex workers, 15,7% are homeless, almost 1% are street children and 47% are roma people 51% are NPS injecting users, 44% are heroin users and 5% injects both NPS &Heroin. 5

Lifetime prevalence of illicit drugs droguri ilicite/ NPS -data from studies (2010-2011)- ESPAD 2011 16 years SPS 18 years YPS 15-34 years GPS 2010 15-34 years Any drug /substance 10 23,2 11,7 9,5 From which SNPP 5,3 9,5 6,0 4,1 COCAINE 2 1,6 0,5 0,5 AMPHETAMINE 3 1,4 0,4 0,1 HEROIN 1 0,3 0,8 0,4

* Risks Assessment of the use of new psychoactive substances among children and young people in Romania, 2011 1.Behaviour patterns of the legal highs intensive users: age: 11-40 years old (significant use at children < 15 years old); high visibility of use; socially integrated youngsters coming from normal families; low adressability to medical/social services. 2. Frequency of use 42,5% - first drug used is NPS /daily basis use, 24,2% -once at every 3 days, 25% - between 4 and 10 uses in the past 30 days, 8,3% < 4 uses in the past 30 days. 3.Poly-drug use 55,9% - have used some other legal products in the past 30 days. (1 of 10 respondents declares frequent use of illicit drugs either). They also use : alcohol, heroin, amphetamine, cocaine, diazepam, valium, rofedex, marijuana, prenadez, tusin. 4. History of use Varies between 1 and 31 months, with an average of 13 months, most frequent answer recorded is 24 months, or 2 years. 5.Administration route Smoking, followed by injecting and sniffing. NPS patterns of use(1)* 7

TDI 2012 3501 clients were assisted in 2012 (in and out patient treatment) for alcohol, tobacco and illicit drugs & NPS use (3362 in 2011): illicit drugs- 1528/43,64% and NPS 685 /19,56% (36% of them are registered as injecting users). 232 convicted drug users were assisted in prison (227 for illicit drugs & NPS use) 8

2012 reversed trend - heroin users are more prevalent; The NPS are less used as primary drug and more like a secondary one, together with alcohol and cannabis. (23,7% cases of NPS as secondary drug) Sex: higher percentage of male users for backslidings (51,1% vs. 38,7%),also for assistance provided to them in opiate use (39,5% vs. 32,2%), NPS use (36,2% vs. 17,8%) and canabis use (12,9% vs. 6,1%) User s age the most of those assisted for NPS use in 2012 were from the 15-29 years age group (75,9%). Onset age - the most prevalent onset age is 15-19 years for the opiates users and 20-29 years for NPS ; It raises the percentage of the < 15 years opiates first time users and < 19 years NPS first time users. 9

Illicit and NPS admissions by usual route of administration (%)) Incidence a decreasing trend of the injecting use and sniffing and increase of the smoking/inhalling and oral use. 10

DRID 2012 - increasing trend Alarming rise for HVB; Rise for HVC at high level (over EU average); Alarming rise for the HIV (over EU average). Posible causes: Harm-reduction services offer seriously diminished after the ending of some UN funded programmes. The injecting frequency increased because of the new patterns of use and swapping from opiates to NPS injecting use. Low rates of adresability to medical/social services. 11

HVB : Stabilization of the HVB prevalence among the male users (from 25,6% to 26%), but a significant increase of the HVB prevalence among the female ones (from 4,4% to 17,7%). the highest prevalence of HVB was registered among the IDUs from the 25-34 years age group (26,8%). HVC: 82,4% HVC prevalence in 2012 (68,5% in 2011) - România enters the top of the European countries with high prevalences of HVC. HVC prevalence is significantly higher among male users 85,4%, compared to the females 65,5%. It is also noticed an increase of the females HVC positive. It increases the HVC prevalence for al the IDUs age groups. 12

HIV: 89 cases (24,5%) of seropositives IDUs from all the 358 IDUs tested for HIV in the privious 6 months. - 3 times higher than one year before. the most spectacular increase of HIV prevalence is registered for the < 25 years age group (over 6 times higher compared to 2011) Health Ministry reports 231 new cases of HIV infected IDUs in 2012 (31% of all new HIV cases for all the risk cathegories). The increasing trend continues to maintain, showing a possible HIV epidemic outbreak in the near future. The BSS 2012 still in progress - preliminary data indicates an HIV prevalence among IDUs of 52,5%. 13

Medical Emergencies after the NPS use, 2012 more than 2/3 of teh emergencies registered for drugs use are for NPS. 90,5% of the cases are <34 years. 10 years NPS users registered by the emergency medical units. NPS reported for 10 of the 133 suicide attempts registered. NPS use related deaths are first time mentioned in 2012 by the emergency units (6 indirect deaths). Polydrug use * Injecting use Crosstabulation Injecting use Not injecting Injecting Total Polydrug use nu Count 756 240 996 % within Polydrug use 75,9% 24,1% 100,0% da Count 262 126 388 % within Polydrug use 67,5% 32,5% 100,0% Total Count 1018 366 1384 % within Polydrug use 73,6% 26,4% 100,0% 14

Geographical Spreading of the NPS Risk areas defined by the share of the non-fatal emergency related to NPS use

DRD, 2012 26 direct drug related deaths registered (all from Bucharest, all with positive toxicologic tests) 16 indirect related to drug use deaths registered 3 DDRD due to acute intoxication with NPS ; 2 IDRD were NPS are suspected, in association with some other illicit drugs. 40 35 30 25 20 15 10 5 0 2006 2007 2008 2009 2010 2011 2012 Decese direct asociate 21 32 33 32 34 15 26 Decese indirect asociate 3 2 1 3 15 26 16 Significant decrease of the average age when dying - 28,03 years for DDRD and 26,56 for IDRD 16

NPS influence on indirect death cases radical change of the pattern of the substances used and administration practices: -very frequent administration from 6 to 8 times a day, especially for the IDUs. -rapid change from ingestion/smoking to injecting use. high availability/low price/ legal status/ perceived as low risk drugs. relatively limited potency (low risk of immediate and lethal overdose compared with the illicit drugs)/ highly addictive. unknown composition, highly contaminated street doses, paraphernalia used in common with others, infectious pathology with acute evolutions. they are not generating death by themselves (only 3 direct drug related deaths recorded for NPS use in 2012) - generate accelerated pathologies that lead to death by medical complications not by overdose. 17

RESPONSES -impact of public policies controlling measures Several government decisions were adopted in order to put under national legal control the marketing and use of some NPS (43 of them were enlisted) but the most important in terms of impact is the Law 194/November 2011(to combat any operation with new substances susceptible of having psychoactive effects). The National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health adopted in february 2011. The mixed inter-institutions controlling teams were set at local level, and their work within the framework of this program have led to some visible results. NAA & partner NGOs national and local NPS use prevention campaigns (THE ABSENT 2011; TOO REBEL TO BE LED (by drugs) 2012 NAA distributed to the partner NGOs from the RHRN 142 500 syringes and bought some other 800000 syringes to be distributed to the NSP in 2013.

SUPPLY INDICATORS NUMBER OF SEIZURES AND QUANTITIES 2012 2 significant seizures of NPS (synthetic cannabinoids JWH-018) originated from Spain and reaching Romania via France Germany Austria Hungariy 2012 significant decrease of the NPS quantities sized (1,5 Kg), compared to 2010 (125,14 kg) and 2011 (4,96 kg). SNPP Cantitate capturată Număr capturi kilograme comprimate 2010 2011 2012 2010 2011 2012 2010 2011 2012 Canabinoizi sintetici 57,024 2,865 1,079 0 0 0 379 115 21 Catinone 50,091 1,863 0,19 324 4 577 480 235 44 Piperazine 6,506 0,023 0,0001 15.094 1.050 89 74 19 19 Pirovalerone 1,800 0.0048 0,03 6 0 2 54 6 10 Triptamine 8,932 0,015 0,078 0 0 0 2 1 73 Mitragin 0,139 0,192 0 0 0 0 4 1 0 Salvinorin 0,648 0,0033 0 0 0 0 15 1 0 Dimetocaină 0 0 0,131 0 0 0 0 0 7 Tabel nr. 2-4: Confiscările de substanţe noi cu proprietăţi psihoactive (kg) în perioada 2010-2012 Sursa: Laboratorul central de analizăşi profil al drogurilor, Inspectoratul General al Poliţiei Române

ROUTINE MONITORING of the implementing of the National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health EVOLUTION OF THE NUMBER OF IDENTIFIED /CONTROLLED DREAM-SHOPS FEBRUARY - MARch 2013 180 160 140 152 158 120 100 80 60 40 20 0 feb.11 132 69 apr.11 67 81 85 50 iun.11 79 58 44 46 aug.11 87 77 4941 oct.11 81 40 dec.11 85 Nr. magazine identificate 47 40 46 50 51 23 34 39 27 28 33 33 33 28 23 2526 13 12 13 14 10 10 10 8 6 8 9 9 1 1 1 0 feb.12 apr.12 iun.12 aug.12 oct.12 Nr. magazine controlate Decembrie 2012 feb.13 20

CONCLUSIONS 1.The new laws (Law no. 194/2011 and COM no. 103/2012) had great effect in stopping the trade of the NPS in the head-shops (all were closed), but the illicit market (on/line market) keep on supplying the consumers. 2. Significant decrease of NPS seizured in the last 2 years 3.INJECTING NPS use and the harm-related issues: High levels of prevalence for HIV and HBV/HVC among the injectors of the NPS. High numbers of the medical emergencies related to NPS use (2/3 of the emergency cases related to drug use were consequences of NPS use 67%) DRD to NPS use appeared (3 direct deaths in 2012 / 2 cases in 2011) 21

http://www.ana.gov.ro/ www.ana.gov.ro 23